Log In
BCIQ
Print this Print this
 

BC-3205

  Manage Alerts
Collapse Summary General Information
Company Nabriva Therapeutics AG
DescriptionPleuromutilin antibiotic
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase I
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today